- RecruitingPHASE2
To Assess the Efficacy, Safety, and Tolerability of INCB000928 in Participants With Fibrodysplasia Ossificans Progressiva
This study is looking into a new medication called INCB000928 for a rare bone condition called Fibrodysplasia Ossificans Progressiva (FOP). We want to see if it's safe and helps improve symptoms. It's a key step in finding better treatments.
For: Fibrodysplasia Ossificans Progressiva (FOP)United States · Argentina · Australia - Active not recruitingPHASE1, PHASE2
INCB000928 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Anemia Due to Myeloproliferative Disorders
This study looks at a new drug, INCB000928, by itself or with ruxolitinib, for people with myelofibrosis who have anaemia (low red blood cells) and need blood transfusions, or have anaemia symptoms. It aims to find a safe and effective dose.
For: Anemia · Post-essential Thrombocythemia Myelofibrosis · Post-polycythemia Vera MyelofibrosisUnited States · Canada · France